A Review of Patient Preferences for Osteoporosis Drug Treatment

被引:40
作者
Hiligsmann, Mickael [1 ]
Bours, Sandrine P. G. [2 ]
Boonen, Annelies [2 ]
机构
[1] Maastricht Univ, Dept Hlth Serv Res, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Internal Med, CAPHRI, NL-6200 MD Maastricht, Netherlands
关键词
Crossover designs; Discrete-choice experiment; Drug therapy; Osteoporosis; Preferences; Review; Satisfaction; DISCRETE-CHOICE EXPERIMENTS; ONCE-WEEKLY ALENDRONATE; POSTMENOPAUSAL WOMEN; HEALTH-CARE; MEDICATION ATTRIBUTES; OPEN-LABEL; ADHERENCE; SATISFACTION; BISPHOSPHONATES; IBANDRONATE;
D O I
10.1007/s11926-015-0533-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poor medication adherence is a major problem in chronic diseases such as osteoporosis that may partially be due to unaddressed patient values and preferences. Data on patient preferences could help clinicians to improve medication adherence and could also be useful in policy decisions and guideline development. This paper aims to identify literature reporting on the preferences of patients for osteoporosis drug medications. Several methods have been used to elicit patient preferences for medications and their characteristics including qualitative research, survey with ranking/rating exercises, discrete-choice experiments and clinical studies (crossover designs, open-label study). All these studies revealed that osteoporotic patients have preferences for medications and their attributes, in particular for less-frequent dosing regimens. Interestingly, variations in the preferences of patients were observed in most studies, suggesting the importance to take into account individual preference in decision-making to improve osteoporosis care.
引用
收藏
页数:10
相关论文
共 42 条
  • [1] How Important Is Mode of Administration in Treatments for Rheumatic Diseases and Related Conditions?
    Bansback, Nick
    Trenaman, Logan
    Harrison, Mark
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (06)
  • [2] Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™
    Barrett-Connor, E.
    Wade, S. W.
    Do, T. P.
    Satram-Hoang, S.
    Stewart, R.
    Gao, G.
    Macarios, D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (02) : 733 - 741
  • [3] Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
    Bonnick, Sydney Lou
    Silverman, Stuart
    Tanner, S. Bobo
    Martens, Mark
    Bachmann, Gloria
    Kohles, Joseph D.
    Civitelli, Roberto
    [J]. JOURNAL OF WOMENS HEALTH, 2009, 18 (07) : 935 - 943
  • [4] Informed decision making in outpatient practice - Time to get back to basics
    Braddock, CH
    Edwards, KA
    Hasenberg, NM
    Laidley, TL
    Levinson, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2313 - 2320
  • [5] Improving health care by understanding patient preferences: The role of computer technology
    Brennan, PF
    Strombom, I
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1998, 5 (03) : 257 - 262
  • [6] Future challenges for the economic evaluation of healthcare - Patient preferences, risk attitudes and beyond
    Bridges, JFP
    [J]. PHARMACOECONOMICS, 2005, 23 (04) : 317 - 321
  • [7] Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
    Chung, Yoon-Sok
    Lim, Sung-Kil
    Chung, Ho-Yeon
    Lee, In-Kyu
    Park, Il-Hyung
    Kim, Ghi-Su
    Min, Yong-Ki
    Kang, Moo-Il
    Chung, Dong-Jin
    Kim, Yong-Ki
    Choi, Woong Hwan
    Shong, Min Ho
    Park, Ji-Hyun
    Byun, Dong-Won
    Yoon, Hyun-Koo
    Shin, Chan Soo
    Lee, Yil-Seob
    Kwon, Nam-Hee
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2009, 85 (05) : 389 - 397
  • [8] Discrete Choice Experiments in Health Economics: A Review of the Literature
    Clark, Michael D.
    Determann, Domino
    Petrou, Stavros
    Moro, Domenico
    de Bekker-Grob, Esther W.
    [J]. PHARMACOECONOMICS, 2014, 32 (09) : 883 - 902
  • [9] Patient preferences for osteoporosis in Spain: a discrete choice experiment
    Darba, J.
    Restovic, G.
    Kaskens, L.
    Balbona, M. A.
    Carbonell, A.
    Cavero, P.
    Jordana, M.
    Prieto, C.
    Molina, A.
    Padro, I.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1947 - 1954
  • [10] Patients' preferences for osteoporosis drug treatment: a discrete choice experiment
    de Bekker-Grob, E. W.
    Essink-Bot, M. L.
    Meerding, W. J.
    Pols, H. A. P.
    Koes, B. W.
    Steyerberg, E. W.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (07) : 1029 - 1037